Real-World study tests Benralizumab's impact on severe asthma control
NCT ID NCT06422078
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 300 adults with severe eosinophilic asthma who are prescribed benralizumab as part of their normal care in Germany. Researchers will track changes in asthma control, lung function, and medication use over one year. The goal is to see how the drug performs outside of controlled clinical trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- benralizumab
- What this could lead to
- If successful, this study could show that benralizumab helps patients with severe asthma achieve better control and reduce their need for other medications in real-world settings.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be influenced by factors other than the drug. It is also limited to Germany, which may not apply to other populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA, BRONCHIAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
RECRUITINGAhrensburg, Germany
-
Research Site
RECRUITINGAnsbach, Germany
-
Research Site
RECRUITINGAschaffenburg, Germany
-
Research Site
RECRUITINGAuerbach, Germany
-
Research Site
RECRUITINGAugsburg, Germany
-
Research Site
RECRUITINGBad Homburg, Germany
-
Research Site
RECRUITINGBerlin, Germany
-
Research Site
RECRUITINGCottbus, Germany
-
Research Site
RECRUITINGDarmstadt, Germany
-
Research Site
RECRUITINGDresden, Germany
-
Research Site
RECRUITINGDüsseldorf, Germany
-
Research Site
RECRUITINGEhringshausen, Germany
-
Research Site
RECRUITINGErkelenz, Germany
-
Research Site
RECRUITINGEssen, Germany
-
Research Site
RECRUITINGFlensburg, Germany
-
Research Site
RECRUITINGFrankfurt am Main, Germany
-
Research Site
RECRUITINGGarmisch-Partenkirchen, Germany
-
Research Site
RECRUITINGHalle, Germany
-
Research Site
RECRUITINGHamburg, Germany
-
Research Site
RECRUITINGHanover, Germany
-
Research Site
WITHDRAWNHeidelberg, Germany
-
Research Site
RECRUITINGHeidelberg, Germany
-
Research Site
RECRUITINGHohenstein-Ernsttahl, Germany
-
Research Site
RECRUITINGItzehoe, Germany
-
Research Site
RECRUITINGJena, Germany
-
Research Site
RECRUITINGLeipzig, Germany
-
Research Site
RECRUITINGLoerrach, Germany
-
Research Site
RECRUITINGLübeck, Germany
-
Research Site
RECRUITINGLüneburg, Germany
-
Research Site
RECRUITINGMarkkleeberg, Germany
-
Research Site
RECRUITINGMönchengladbach, Germany
-
Research Site
RECRUITINGNeuruppin, Germany
-
Research Site
RECRUITINGNuremberg, Germany
-
Research Site
RECRUITINGPapenburg, Germany
-
Research Site
RECRUITINGRostock, Germany
-
Research Site
RECRUITINGSaalfeld, Germany
-
Research Site
RECRUITINGSpardorf, Germany
-
Research Site
RECRUITINGWeißenburg, Germany
-
Research Site
RECRUITINGWilhelmshaven, Germany
-
Research Site
RECRUITINGWürzburg, Germany
-
Research Site
RECRUITINGZossen, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Beyond breathing: could an asthma drug lift emotional burdens for patients and partners?
- Smart inhalers track Fasenra's asthma control over full dosing cycle
- CT scan could predict asthma drug success, saving months of trial and error
- New asthma drug shows promise in real-world greek study
- Real-World study checks if benralizumab tames severe asthma in taiwan
- Severe asthma drug may boost daily steps, study hopes